zolpidem has been researched along with Disease Exacerbation in 2 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Excerpt | Relevance | Reference |
---|---|---|
"Psychiatric symptoms and catatonia are key components of the clinical presentation of paraneoplastic encephalitis; additionally symptoms can be long-lasting and often difficult to treat." | 5.43 | Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis. ( Amorim, E; McDade, EM, 2016) |
"Psychiatric symptoms and catatonia are key components of the clinical presentation of paraneoplastic encephalitis; additionally symptoms can be long-lasting and often difficult to treat." | 1.43 | Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis. ( Amorim, E; McDade, EM, 2016) |
"The presentation of catatonia in autism and the use of ECT in children are discussed, and the available literature reviewed." | 1.30 | Catatonia, autism, and ECT. ( Bates, GD; Bentham, P; Murali, V; Zaw, FK, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amorim, E | 1 |
McDade, EM | 1 |
Zaw, FK | 1 |
Bates, GD | 1 |
Murali, V | 1 |
Bentham, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders[NCT03980366] | 1 participants (Actual) | Interventional | 2019-03-15 | Terminated (stopped due to We have not obtained additional subjects and chose to terminate/close this study.) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for zolpidem and Disease Exacerbation
Article | Year |
---|---|
Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis.
Topics: Aged; Catatonia; Disease Progression; Female; Humans; Hypnotics and Sedatives; Ovarian Neoplasms; Pa | 2016 |
Catatonia, autism, and ECT.
Topics: Adolescent; Autistic Disorder; Catatonia; Combined Modality Therapy; Depressive Disorder; Disease Pr | 1999 |